Pharmallaney Ltd - Filleted accounts

Registered number

07352168

Pharmallaney Ltd

Unaudited Filleted Accounts

31 March 2026

Pharmallaney Ltd
Registered number:		07352168
Balance Sheet
as at 31 March 2026

Notes			2026			2025
£				£
Fixed assets
Tangible assets	4		-			2,160

Current assets
Debtors	5	25,073			1,736
Cash at bank and in hand		11,167			10,313
		36,240			12,049

Creditors: amounts falling due within one year	6	(29,336)			(3,864)

Net current assets			6,904			8,185

Total assets less current liabilities			6,904			10,345


Provisions for liabilities			-			(410)


Net assets			6,904			9,935

Capital and reserves
Called up share capital			2			2
Profit and loss account			6,902			9,933

Shareholders' funds			6,904			9,935

The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.




Gaynor Mollaney
Director
Approved by the board on 27 August 2026

Pharmallaney Ltd
Notes to the Accounts
for the period from 1 September 2025 to 31 March 2026


1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

2	Company Closure
	The directors have decided that they no longer wish to continue trading and intend to close the company down and for this reason the accounts have not been prepared on a going concern basis.

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Tangible fixed assets
	Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

	Office equipment	over 6.66 years
	Computer equipment	over 3 years

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.


3	Employees			2026		2025
Number					Number

	Average number of persons employed by the company			0		2


4	Tangible fixed assets
		Plant and machinery etc		Motor vehicles		Total
£			£		£
	Cost
	At 1 September 2025	2,727		3,428		6,155
	Disposals	(2,727)		(3,428)		(6,155)
	At 31 March 2026	-		-		-

	Depreciation
	At 1 September 2025	1,734		2,261		3,995
	On disposals	(1,734)		(2,261)		(3,995)
	At 31 March 2026	-		-		-

	Net book value
	At 31 March 2026	-		-		-
	At 31 August 2025	993		1,167		2,160


5	Debtors			2026		2025
£					£

	Trade debtors			25,073		1,400
	Other debtors			-		336
				25,073		1,736


6	Creditors: amounts falling due within one year			2026		2025
£					£

	Trade creditors			-		788
	Taxation and social security costs			8,602		1,771
	Other creditors			20,734		1,305
				29,336		3,864


7	Related party transactions

	None noted


8	Transactions with Directors

	During the year the Directors of Pharmallaney Ltd used a current account with the company to record amounts due to them and amounts drawn by them. The account shows an amount owed to the directors as at 31st March 2026 of £19,533.89(2025: £105.33). The amount is repayable on demand and carries interest.


9	Controlling party

	Mrs Gaynor Mollaney and Mr Gerald Mollaney each hold 50% of the share capital of the company. As Mrs Gaynor Mollaney works full time in the business and controls the daily running of the company, she is actually the company's ultimate controlling party.


10	Other information

	Pharmallaney Ltd is a private company limited by shares and incorporated in England. Its registered office is:
	34 Maryport Street
	Usk
	Wales
	NP15 1AE